Communiversity Offers Class on Building Your Personal Brand
Mike Taylor is a proven branding wizard, business strategist and storyteller. Taylor has branded everything from hardware, restaurants, cosmetics, health and people. Hes worked at top consumer product corporations, creative agencies, leading retailers and professional consulting. Taylor is also the founder of Exemplary Brands Work, which focuses on helping people achieve success by discovering and launching their personal brand.
In this four-week course, you will:
- Discover your brand what makes you unique and valuable.
- Focus your brand on different audiences that are critical to your success.
- Build your brand in conversations, writings and digital media.
- Create your personal brand vision getting you out into the market.
Building Your Personal Brand
Mondays, February 20 March 13, 2017, 6:30 pm 8:30 PM, $159
2220 Victory Parkway, Cincinnati, Ohio 45206.
Free Parking
Register online at
or call us at 513-556-6932.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.